Clinical Trial Update: Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults [Phase 2]

View source ↗

Summary

The document notes a Phase 2 clinical trial evaluating sub-dissociative dose ketamine for vaso-occlusive pain episodes in children and young adults with sickle …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Mohsen Saidinejad | Conditions: Sickle Cell Disease, Vaso-Occlusive Pain Episode in Sickle Cell Disease | Phase 2 | Status: RECRUITING